References
- Kumar MSA, Heifets M, Moritz MJ et al. Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years. Transplantation 2006;81:832-839
- Meier-Kriesche H-U, Schold JD, Srinivas TR et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004;4:378-383
- Moreso F., Ibernon M., Goma M. et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6:747-752
- Moriatsu Miyagi, Yukio Ishikawa, Sonoo Mizuiri et al. Significance of subclinical rejection in early renal allograft biopsies for chronic allograft dysfunction. Clin Transplant 2005; 19:456-465
- Nankivell BJ, Chapman JR. The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 2006; 6:2006-2012
- Nankivell BJ, Borrows RJ, Fungs CLS et al. Natural history, risks factors and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78:242-249
- Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55:713-723
- Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Transplantation 1995; 59:511-514
- Terence Y-S Kee, Chapman JR, O'Connell PJ et al. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 2006; 82:36-42